Report : Middle East & Africa Microcarriers Market Forecast to 2030 - Regional Analysis - by Product (Media & Reagents and Microcarrier Beads), Equipment (Bioreactors, Culture Vessels, and Others), Application (Biopharmaceutical Production, Cell and Gene Therapy, Tissue Engineering and Regenerative Medicine, and Others), and End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations & Contract Manufacturing Organizations, and Academic & Research Institutes)
At 11.5% CAGR, Middle East & Africa Microcarriers Market is Speculated to be Worth US$ 88.59 Million by 2030, says Business Market Insights
According to Business Market Insights research, the Middle East & Africa microcarriers market was valued at US$ 37.07 million in 2022 and is expected to reach US$ 88.59 million by 2030, registering a CAGR of 11.5% from 2022 to 2030. Automation of cell and gene therapy manufacturing services and increasing popularity of outsourcing cell and gene therapy manufacturing are among the critical factors attributed to the Middle East & Africa microcarriers market expansion.
Incorporating automation in cell and gene therapy manufacturing would lead to a reduced risk of contamination, improved consistency, and decreased cost of production. Lonza Cocoon and the CliniMACS Prodigy system from Miltenyi are a few of the devices available in the market that have been designed to enable the automation of most sequential unit operations for a CAR-T process within a single system. The rising demand for cell and gene therapies has shifted production from a small-volume process to a large-volume process worldwide. The progress of cell and gene therapy from an academic and clinical setting to mass production and commercialization further propels the demand for automation in commercial manufacturing. Thus, automation is emerging as a new trend in the microcarriers market.
On the contrary, high cost of biologics and cell-based therapies hampers the Middle East & Africa microcarriers market.
Based on product, the Middle East & Africa microcarriers market is bifurcated into microcarriers beads and media & reagents. The microcarriers beads segment held 66.9% share of Middle East & Africa microcarriers market in 2022, amassing US$ 24.79 million. It is projected to garner US$ 60.37 million by 2030 to expand at 11.8% CAGR during 2022-2030.
In terms of equipment, the Middle East & Africa microcarriers market is categorized into bioreactors, culture vessels, and others. The bioreactors segment held 64.8% share of Middle East & Africa microcarriers market in 2022, amassing US$ 24.03 million. It is projected to garner US$ 58.59 million by 2030 to expand at 11.8% CAGR during 2022-2030.
Based on application, the Middle East & Africa microcarriers market is segmented into biopharmaceutical production, cell and gene therapy, tissue engineering and regenerative medicine, and other. The biopharmaceutical production beads segment held 52.1% share of Middle East & Africa microcarriers market in 2022, amassing US$ 19.30 million. It is projected to garner US$ 47.86 million by 2030 to expand at 12.0% CAGR during 2022-2030. Further, biopharmaceutical production segment is categorized into therapeutic protein production and vaccine production.
Based on end user, the Middle East & Africa microcarriers market is segmented into pharmaceutical & biotechnology companies, contract research organizations & contract manufacturing organizations, and academic & research institutes. The pharmaceutical & biotechnology companies segment held 55.6% share of Middle East & Africa microcarriers market in 2022, amassing US$ 20.61 million. It is projected to garner US$ 50.46 million by 2030 to expand at 11.8% CAGR during 2022-2030.
By country, the Middle East & Africa microcarriers market has been categorized into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Our regional analysis states that Saudi Arabia captured 36.9% share of Middle East & Africa microcarriers market in 2022. It was assessed at US$ 13.67 million in 2022 and is likely to hit US$ 33.81 million by 2030, exhibiting a CAGR of 12.0% during 2022-2030.
Key players operating in the Middle East & Africa microcarriers market are Bio-Rad Laboratories Inc, Sartorius AG, Danaher Corp, Eppendorf SE, Asahi Kasei Corp, and Polysciences Inc, among others.
- In May 2022, The company released beadMATRIX for mesenchymal stromal cells (MSCs). beadMATRIX are ready-to-use, pre-coated microcarriers free of animal components that are used to cultivate superior MSCs in vitro. Shaker bags, stirred tanks, vertical wheel bioreactors, and shaker flasks are the perfect environments for beadMATRIX.
Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@businessmarketinsights.com